<DOC>
	<DOCNO>NCT03080571</DOCNO>
	<brief_summary>Stroke lead cause morbidity mortality.Acute ischemia cause irreversible damage neuron glial cell , lead functional deficit chronic sequela variable degree spontaneous recovery function . Stem cell show enhance recovery multiple immunomodulatory effect , neoangiogenesis neurogenesis . We conduct prospective randomised end observer blind study evaluate primarily safety intraarterial autologous stem cell deliver ipsilateral middle cerebral artery acute subacute stroke patient ( 0-15 day post ictus ) .Secondarily aim evaluate outcome basis clinical evaluation follow image</brief_summary>
	<brief_title>Intraarterial Stem Cells Subacute Ischemic Stroke</brief_title>
	<detailed_description>1 . This study do period one half year July 2015 December 2016 . A total 229 patient present acute middle cerebral artery stroke admit Post graduate institute medical education research evaluate recruitment study . 2 . Participants satisfy inclusion criterion randomize 1 week control stem cell infusion test group within 15 day stroke onset . 3 . Investigators evaluate 20 patient , 10 control stem cell infusion test group . 4 . Participants test group infuse autologous bone marrow mononuclear cell intraarterial route use microcatheter place proximal ipsilateral M1 segment MCA . Participants control group receive stem cell therapy . Rest pharmacological treatment physiotherapy similar group period 6 month . 5 , Participants evaluate clinical radiological follow 6 month .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>Requires presence follow 1 . Age range 2080 year symptoms 2 . Signs clinically definite MCA stroke ( 0 14 day post ictus ) 3 . National Institute Health Stroke Scale ( NIHSS ) &gt; 7 , 4 . Stroke clinically image conform MCA territory , 5 . Recanalization/patency involve M1 segment MCA image 6 . Patency carotid artery intraarterial access cerebral circulation Requires presence follow 1. cerebral hemorrhage CT/MRI 2 . Imaging evidence M1MCA segment complete occlusion 3 . Hemodynamic instability 4 . Known defect clot platelet function 5 . Severe comorbidity preclude intraarterial intervention 6 . Hepatic renal dysfunction 7 . Pregnant patient 8 . Patient likely unavailable followup 9 . Patients evidence chronic illness advance cancer 10 . Patient already dependent activity daily live present acute stroke i.e . pre stroke mRS &gt; 3 11 . Refusal give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>